Biomarkers for Diabetes

Biomarker”, are called “molecular marker” or a “signature molecule”. These viewed as direct or indirect markers of the extent of disease as they lay outside in a casual way. HbA1c is considered a biomarker for a risk factor that is for retinopathy, nephropathy and other vascular diseases. Biomarkers enable preventive measures to be applied at the subclinical stage and the responses to preventive or therapeutic measures to be monitored. Cases over the past two decades have yielded sample sets, mostly blood products and urine from a large category of patients with both type 1 and type 2 diabetes.

  • Carbonyl stress
  • Pulse wave analysis
  • Auto fluorescence
  • Biomarkers of vascular function in diabetes

Related Conference of Biomarkers for Diabetes

November 22-23, 2024

20th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands
November 27-28, 2024

14th World Congress on Endocrinology and Diabetes

Paris, France
February 24-25, 2025

34th European Diabetes Congress

London, UK
March 10-11, 2025

4th Global Summit on Physiology and Metabolism of Thyroid

Singapore City, Singapore
March 17-18, 2025

5th European Endocrinology and Diabetes Congress

Paris, France
April 10-11, 2025

4th International Summit on Hormonal Disorders

Dubai, UAE
April 10-11, 2025

5th World Congress on Endocrine and Diabetes

Dubai, UAE
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland

Biomarkers for Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in